Yang H - Search Results

1

Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma.

Yang H, Lin M, Xiong FX, Yang Y, Nie X, Zhou RL. Yang H, et al. Among authors: yang y. Oncol Lett. 2010 Jan;1(1):31-36. doi: 10.3892/ol_00000005. Epub 2010 Jan 1. Oncol Lett. 2010. PMID: 22966251 Free PMC article.

2

LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Yang H, Xiong FX, Lin M, Yang Y, Nie X, Zhou RL. Yang H, et al. Among authors: yang y. J Cancer Res Clin Oncol. 2010 Feb;136(2):275-81. doi: 10.1007/s00432-009-0659-4. Epub 2009 Aug 19. J Cancer Res Clin Oncol. 2010. PMID: 19690886

3

LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.

Yang Y, Yang H, McNutt MA, Xiong F, Nie X, Li L, Zhou R. Yang Y, et al. Among authors: yang h. Oncol Rep. 2008 Nov;20(5):1077-83. Oncol Rep. 2008. PMID: 18949404

4

Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.

Yang H, Xiong F, Wei X, Yang Y, McNutt MA, Zhou R. Yang H, et al. Among authors: yang y. Cancer Lett. 2010 Aug 28;294(2):236-44. doi: 10.1016/j.canlet.2010.02.006. Epub 2010 Mar 3. Cancer Lett. 2010. PMID: 20202745

5

LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.

Yang H, Xiong F, Qi R, Liu Z, Lin M, Rui J, Su J, Zhou R. Yang H, et al. J Surg Oncol. 2010 Apr 1;101(5):363-9. doi: 10.1002/jso.21489. J Surg Oncol. 2010. PMID: 20358632

6

Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients.

Yang H, Lin M, Xiong F, Yang Y, Nie X, McNutt MA, Zhou R. Yang H, et al. Among authors: yang y. Surg Today. 2011 Jun;41(6):810-7. doi: 10.1007/s00595-010-4338-5. Epub 2011 May 28. Surg Today. 2011. PMID: 21626328

7

Reduced expression of argininosuccinate lyase is closely associated with postresectional survival in hepatocellular carcinoma: an immunohistochemistry study of 61 cases.

Yang H, Zhai G, Ji X, Su J, Lin M. Yang H, et al. Appl Immunohistochem Mol Morphol. 2012 Dec;20(6):602-6. doi: 10.1097/PAI.0b013e318250c814. Appl Immunohistochem Mol Morphol. 2012. PMID: 22531684

8

Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.

Li L, Shan Y, Yang H, Zhang S, Lin M, Zhu P, Chen XY, Yi J, McNutt MA, Shao GZ, Zhou RL. Li L, et al. Among authors: yang h. Anat Rec (Hoboken). 2011 Jul;294(7):1135-42. doi: 10.1002/ar.21421. Epub 2011 May 26. Anat Rec (Hoboken). 2011. PMID: 21618708 Free article.

9

The deubiquitinating enzyme complex BRISC is required for proper mitotic spindle assembly in mammalian cells.

Yan K, Li L, Wang X, Hong R, Zhang Y, Yang H, Lin M, Zhang S, He Q, Zheng D, Tang J, Yin Y, Shao G. Yan K, et al. Among authors: yang h. J Cell Biol. 2015 Jul 20;210(2):209-24. doi: 10.1083/jcb.201503039. J Cell Biol. 2015. PMID: 26195665 Free PMC article.

10

Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients.

Zhai G, Yang H, Ji X, Xiong F, Su J, McNutt MA, Li X. Zhai G, et al. Among authors: yang h. Med Oncol. 2012 Dec;29(4):2744-9. doi: 10.1007/s12032-011-0139-y. Epub 2011 Dec 30. Med Oncol. 2012. PMID: 22207410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,450 results

Search Page

Filters